Ophthalmology Education and CME

Select a Specialty

Transitioning Treatment in Diabetic Retinopathy
CME

Transitioning Treatment in Diabetic Retinopathy

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 7/18/2020
Credit Type(s): CME | Credit: 0.75

Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, offering delayed or arrested disease progression and the…

go to activity»
Visual Reality Diabetic Retinopathy
COPE

Visual Reality: Diabetic Retinopathy

This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.

Expiration Date: 6/1/2020
Credit Type(s): COPE | Credit: 1

Diabetic retinopathy (DR) continues to be a leading cause of blindness. However, early diagnosis and prompt treatment with laser and/or intravitreal anti-vascular…

go to activity»
Evolution of IOL Performance

The Evolution of IOL Performance: BioMaterial, BioMechanics, BioOptics

This activity is produced by SLACK Incorporated and sponsored by Alcon.

June 11, 2019

Cataract surgeons have used the IOL platforms they believe to provide the best possible visual outcomes for their patients. Although IOLs are typically reliable and…

go to activity»
Innovation: Looking into the Future of Ophthalmology

Innovation: Looking into the Future of Ophthalmology

Sponsored by Alcon
US-ORA-18-E-2678k

June 10, 2019

During Hawaiian Eye 2019, key opinion leaders gathered for an Industry Expert Theater panel discussion, sponsored by Alcon, to discuss the future technological…

go to activity»
Advances in Cataract Surgical Techniques and Postoperative Care
CME

Advances in Cataract Surgical Techniques and Postoperative Care

This activity is supported by educational grants from Alcon Laboratories, Inc. and EyePoint Pharmaceuticals, Inc.

Expiration Date: 5/25/2020
Credit Type(s): CME | Credit: 1.25

New techniques for cataract surgery have emerged in rapid succession over the past few years. Some of these techniques have been demonstrated to provide clinically…

go to activity»
Improving the Burden of Treatment for Age-related Macular Degeneration through Advances in Delivery
CME

Improving the Burden of Treatment for Age-related Macular Degeneration Through Advances in Delivery

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 5/2/2020
Credit Type(s): CME | Credit: 0.75

Intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy has revolutionized the treatment of age-related macular degeneration (AMD), but it has…

go to activity»
Ocular Surface Diseases, Disorders, and Dysfunctions®: Volume 5, Number 1
CMECOPE

Ocular Surface Diseases, Disorders, and Dysfunctions®: Volume 5, Number 1

This activity is supported by an educational grant from Shire.

Expiration Date: 7/1/2020
Credit Type(s): CME / COPE | Credit: 1.25

Early identification and prompt management of patients with ocular surface disease (OSD) can lessen disease severity and achieve earlier resolution. However, OSD…

go to activity»
A Clear Choice for Patients and Practices is CLEAR CARE® PLUS

A Clear Choice for Patients and Practices is CLEAR CARE® PLUS

This activity is sponsored by Alcon.

June 14, 2019

Learn about a lens care solution that can make a difference for your patients and your practice….

go to activity»
M539
CME

Cole Eye Institute Retina Summit 2019 Highlights

This activity is supported by an educational grant from Alcon Vision, LLC, Genentech, Inc., Regeneron Pharmaceuticals Inc.

Expiration Date: 6/11/2020
Credit Type(s): CME | Credit: 1

…

go to activity»
Latanoprostene Bunod and its Nitric Oxide Moiety
CME

Latanoprostene Bunod and its Nitric Oxide Moiety

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 5/21/2020
Credit Type(s): CME | Credit: 0.25

This educational activity will discuss modulation of aqueous humor outflow by nitric oxide and the efficacy of latanoprost bunod in treating open angle glaucoma….

go to activity»
M439_HEA003
CME

When Anti-VEGF Agents Don’t Work: Using Intravitreal Steroids Alone or in Combination to Treat DME/DR—Vision Is More Than Just Best Corrected Visual Acuity in Diabetic Macular Edema

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 4/30/2020
Credit Type(s): CME | Credit: 0.25

Explore the treatment options for a patient with diabetes and blurry vision presented by Dr Roger Goldberg with faculty discussion of treatment strategies and timing to…

go to activity»
Incorporating Advanced Technology IOLs into Clinical Practice

Incorporating Advanced Technology IOLs into Clinical Practice

Sponsored by Alcon.
US-RES-18-E-2541k

May 1, 2019

During Hawaiian Eye 2019, key opinion leaders gathered for an Industry Expert Theater panel discussion….

go to activity»